Dual Inhibition of Ornithine Decarboxylase and A(1) Adenosine Receptor Efficiently Suppresses Breast Tumor Cells

Personized treatment of breast cancer is still a challenge, and more treatment options for breast cancer are warranted. Combination therapies have been a highly appreciated strategy for breast cancer treatment in recent years, and the development of new combination therapies could improve patient ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hongyan, Li, Qizhang, Wang, Jing, Pan, Jing, Su, Zhengding, Liu, Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991832/
https://www.ncbi.nlm.nih.gov/pubmed/33777791
http://dx.doi.org/10.3389/fonc.2021.636373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991832/
https://www.ncbi.nlm.nih.gov/pubmed/33777791
http://dx.doi.org/10.3389/fonc.2021.636373

Ejemplares similares